Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. MP Freeman, JR Hibbeln, KL Wisner, JM Davis, D Mischoulon, M Peet, ... Journal of Clinical psychiatry 67 (12), 1954, 2006 | 1052 | 2006 |
Nutritional medicine as mainstream in psychiatry J Sarris, AC Logan, TN Akbaraly, GP Amminger, V Balanzá-Martínez, ... The Lancet Psychiatry 2 (3), 271-274, 2015 | 721 | 2015 |
Quality of life assessments in major depressive disorder: a review of the literature GI Papakostas, T Petersen, Y Mahal, D Mischoulon, AA Nierenberg, ... General hospital psychiatry 26 (1), 13-17, 2004 | 464 | 2004 |
Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence D Mischoulon, M Fava The American journal of clinical nutrition 76 (5), 1158S-1161S, 2002 | 446 | 2002 |
Diet and depression: exploring the biological mechanisms of action W Marx, M Lane, M Hockey, H Aslam, M Berk, K Walder, A Borsini, J Firth, ... Molecular psychiatry 26 (1), 134-150, 2021 | 433 | 2021 |
Adjunctive nutraceuticals for depression: a systematic review and meta-analyses J Sarris, J Murphy, D Mischoulon, GI Papakostas, M Fava, M Berk, CH Ng American Journal of Psychiatry 173 (6), 575-587, 2016 | 401 | 2016 |
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials GI Papakostas, RC Shelton, JM Zajecka, B Etemad, K Rickels, A Clain, ... American Journal of Psychiatry 169 (12), 1267-1274, 2012 | 344 | 2012 |
Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression J Sarris, D Mischoulon, I Schweitzer The Journal of clinical psychiatry 72 (1), 13263, 2011 | 339 | 2011 |
S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind … GI Papakostas, D Mischoulon, I Shyu, JE Alpert, M Fava American Journal of Psychiatry 167 (8), 942-948, 2010 | 332 | 2010 |
Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study MH Rapaport, AA Nierenberg, PJ Schettler, B Kinkead, A Cardoos, ... Molecular psychiatry 21 (1), 71-79, 2016 | 291 | 2016 |
Relationship between sleep disturbance and depression, anxiety, and functioning in college students M Nyer, A Farabaugh, K Fehling, D Soskin, D Holt, GI Papakostas, ... Depression and anxiety 30 (9), 873-880, 2013 | 283 | 2013 |
Cell-extracellular matrix interactions can regulate the switch between growth and differentiation in rat hepatocytes: reciprocal expression of C/ΕΒΡα and immediate-early growth … B Rana, D Mischoulon, Y Xie, NLR Bucher, SR Farmer Molecular and cellular biology 14 (9), 5858-5869, 1994 | 268 | 1994 |
Nutrition and depression: focus on folate. JE Alpert, D Mischoulon, AA Nierenberg, M Fava | 245 | 2000 |
Effects of smartphone use with and without blue light at night in healthy adults: A randomized, double-blind, cross-over, placebo-controlled comparison JY Heo, K Kim, M Fava, D Mischoulon, GI Papakostas, MJ Kim, DJ Kim, ... Journal of psychiatric research 87, 61-70, 2017 | 242 | 2017 |
Effects of mindfulness-based cognitive therapy on body awareness in patients with chronic pain and comorbid depression M De Jong, SW Lazar, K Hug, WE Mehling, BK Hölzel, AT Sack, F Peeters, ... Frontiers in psychology 7, 967, 2016 | 229 | 2016 |
A double‐blind, randomized, pilot dose‐finding study of maca root (L. meyenii) for the management of SSRI‐induced sexual dysfunction CM Dording, L Fisher, G Papakostas, A Farabaugh, S Sonawalla, M Fava, ... CNS neuroscience & therapeutics 14 (3), 182-191, 2008 | 221 | 2008 |
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment RH Perlis, D Mischoulon, JW Smoller, YJY Wan, S Lamon-Fava, KM Lin, ... Biological psychiatry 54 (9), 879-883, 2003 | 221 | 2003 |
A double-blind, randomized trial of St John's wort, fluoxetine, and placebo in major depressive disorder M Fava, J Alpert, AA Nierenberg, D Mischoulon, MW Otto, J Zajecka, ... Journal of clinical psychopharmacology 25 (5), 441-447, 2005 | 216 | 2005 |
Folate in depression: efficacy, safety, differences in formulations, and clinical issues M Fava, D Mischoulon The Journal of clinical psychiatry 70 (suppl 5), 7377, 2009 | 215 | 2009 |
Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses GI Papakostas, D Öngür, DV Iosifescu, D Mischoulon, M Fava European Neuropsychopharmacology 14 (2), 135-142, 2004 | 201 | 2004 |